The present invention relates to combination therapies, it uses anti-CD20/ AntiCD3 McAbs bispecific antibody and 4-1BB (CD137) excitant, particularly 4-1BBL trimers use combination therapy using these combination therapies for treating cancer and method comprising antigen binding molecules.